PainChek Limited (ASX: PCK) aspires to lead the market in the innovative pain assessment products and offer services to help improve the quality of life, for people suffering from pain. The company’s pain assessment device PainChek® has received regulatory clearance from both Australia and Europe. The company is domiciled in Sydney and its CEO and MD is Mr Philip Daffas.

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK